Dermatitis

Well+Good Releases Highly Anticipated Wellness Trends Report

Retrieved on: 
Wednesday, December 6, 2023

NEW YORK, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Well+Good , a leading health and wellness media brand, announced today the launch of its highly anticipated Wellness Trends 2024 report.

Key Points: 
  • NEW YORK, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Well+Good , a leading health and wellness media brand, announced today the launch of its highly anticipated Wellness Trends 2024 report.
  • The report names the health, wellness, and self-care trends that will shape the industry in the year ahead.
  • The annual Wellness Trends report makes predictions for the most groundbreaking innovations that will dominate the wellness industry in the coming year.
  • To view the full Wellness Trends report, visit: https://www.wellandgood.com/fitness-wellness-trends/

Textile Evolution: Taiwan Textile Federation's TEPP Project Inspires Sustainable Innovation Beyond 2023

Retrieved on: 
Tuesday, December 5, 2023

Taipei, Taiwan, Dec. 05, 2023 (GLOBE NEWSWIRE) -- In a resounding success, the Textile Export Promotion Project (TEPP), spearheaded by the Taiwan Textile Federation in 2023, has showcased remarkable achievements, propelling the initiative forward into 2024.

Key Points: 
  • Taipei, Taiwan, Dec. 05, 2023 (GLOBE NEWSWIRE) -- In a resounding success, the Textile Export Promotion Project (TEPP), spearheaded by the Taiwan Textile Federation in 2023, has showcased remarkable achievements, propelling the initiative forward into 2024.
  • The TEPP has been a driving force behind the evolution of Taiwan's textile industry, which boasts a comprehensive production system developed over more than 60 years.
  • Particularly, the global significance of innovative textiles with functionalities and eco-friendly attributes has positioned Taiwan prominently in international markets.
  • Beyond its initial focus on aligning Taiwan's outdoor sports textile products with global standards, the TEPP has expanded its scope in 2023.

NuMe Introduces Acai-Infused Hair Care Trio for Luxurious Locks

Retrieved on: 
Sunday, December 24, 2023

SANTA MONICA, Calif., Dec. 24, 2023 /PRNewswire/ -- NuMe, an innovative name in the beauty industry, is thrilled to unveil a trio of Acai-infused hair care products that promise to transform your hair care routine.

Key Points: 
  • SANTA MONICA, Calif., Dec. 24, 2023 /PRNewswire/ -- NuMe, an innovative name in the beauty industry, is thrilled to unveil a trio of Acai-infused hair care products that promise to transform your hair care routine.
  • Discover the magic of Acai with NuMe's Acai Shampoo, Acai Conditioner, and Acai Hair Mask, available now on NuMe Official Website .
  • Lock in Acai power with NuMe's Acai Hair Mask formulated with Omega 3,6, 9 and vitamins B, C and E to soften and moisturize hair strands.
  • Ensuring that hair follicles receive adequate oxygen and nutrition, acai facilitates the natural progression of the hair growth cycle.

New Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation

Retrieved on: 
Thursday, December 21, 2023

NEW YORK, Dec. 21, 2023 /PRNewswire-PRWeb/ -- Researchers at the Icahn School of Medicine at Mount Sinai have gained a deeper understanding of the nuanced roles of JAK inhibitors, or modulators, in inflammation across various cell types and tissues. Their findings suggest a more precise approach is required to potentially expand JAK inhibitor use to a wider range of allergy and inflammatory disorders. Details on the findings were published in the December 21, 2023, issue of the journal Cell (DOI: 10.1016/j.cell.2023.11.027).

Key Points: 
  • Their findings suggest a more precise approach is required to potentially expand JAK inhibitor use to a wider range of allergy and inflammatory disorders.
  • Current JAK inhibitors work well against inflammation in diseases like eczema, but the study suggests a need for a nuanced approach in modulating JAK activity for conditions like asthma.
  • The study showed that activated JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, where it suppresses lung inflammation.
  • In the lung neurons of the mice, the JAK1 mutant protein reduced inflammation caused by exposure to mold by producing substances that suppress inflammation.

Zerigo Health Appoints Tim Raducha-Grace as Chief Platform Officer

Retrieved on: 
Tuesday, December 19, 2023

SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- Zerigo Health, a digital health platform for the treatment of chronic skin conditions, today announces the appointment of Tim Raducha-Grace as Chief Platform Officer.

Key Points: 
  • SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- Zerigo Health , a digital health platform for the treatment of chronic skin conditions, today announces the appointment of Tim Raducha-Grace as Chief Platform Officer.
  • Raducha-Grace joins Zerigo Health after leading commercial and product teams across the healthcare industry, including venture-backed and Fortune 20 companies.
  • Most recently, he served as Head of Clinical Partnerships at Harbor Health, where he built a high performing clinically integrated network including partnerships with leading health systems.
  • I'm excited to join the Zerigo Health team to expand our platform and get it in the hands of the patients who need it most.

Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist, in Atopic Dermatitis

Retrieved on: 
Tuesday, November 28, 2023

By blocking activation of MRGPRX2 and degranulation of mast cells, EP262 has the potential to effectively treat multiple mast cell mediated diseases with an initial focus on chronic urticaria (hives) and atopic dermatitis (eczema).

Key Points: 
  • By blocking activation of MRGPRX2 and degranulation of mast cells, EP262 has the potential to effectively treat multiple mast cell mediated diseases with an initial focus on chronic urticaria (hives) and atopic dermatitis (eczema).
  • EP262 represents a novel, targeted approach to the treatment of these disorders with the potential for once-daily oral administration without the side effects observed with other approaches.
  • The study will evaluate clinical scores as well as histological and transcriptomic markers in lesional skin biopsies.
  • “With the initiation of our EASE clinical proof-of-concept study, we look forward to evaluating whether the promising preclinical findings with EP262 translate to patients with atopic dermatitis,” said Christian Weyer, M.D., M.A.S, Chief Medical Officer at Escient.

Global Diaper (Adult and Baby Diaper) Market Insights & Forecast to 2026: Growing Demand for Biodegradable Diapers - ResearchAndMarkets.com

Retrieved on: 
Monday, November 27, 2023

As the number of working women increases, so will the market for baby diapers.

Key Points: 
  • As the number of working women increases, so will the market for baby diapers.
  • As a result, household demand for diapers has been growing, especially among less affluent consumers.
  • Growing health concern due to the presence of harmful chemicals in the baby diapers is projected to restrict market growth.
  • Sodium polyacrylate is basically used in the baby diapers and this has allergic reactions on the baby skins.

Dermatologist Elizabeth Mullans Shares Her Top 5 Skincare Tips to Help Avoid and Relieve Dry Skin this Winter

Retrieved on: 
Tuesday, November 21, 2023

1. Moisturize generously. Baths, showers, indoor heat, weather changes, and low humidity can all strip away the skin's natural oils, leaving you with dry, chapped, itchy skin. In the winter, I recommend using a gentle moisturizer at least twice a day after cleansing-- in the morning and before bed at night, like CeraVe Moisturizing Cream, Aveeno Eczema Cream, or Eucerin Advanced Repair Cream, to smooth and hydrate the skin, as well as reduce the appearance of blemishes, and plump fine lines and wrinkles.

Key Points: 
  • To help protect against dry skin this winter, and in light of National Healthy Skin Month, Elizabeth Mullans, M.D., board-certified dermatologist and skincare expert at Uptown Dermatology , is sharing her top skincare tips to help maintain healthy skin.
  • “Dry skin can be uncomfortable and even painful, but there are ways to prevent and alleviate this issue.”
    Below, Dr. Mullans shares her top 5 simple steps to help protect against dry skin this winter:
    1.
  • But those with skin sensitivities are more prone to skin damage from scrubbing which can result in dry, irritated skin.
  • “Remember, prevention is key when it comes to maintaining healthy skin all year round, so be proactive with your winter skincare routine,” says Mullans.

Human medicines European public assessment report (EPAR): Ebglyss, Lebrikizumab, Date of authorisation: 16/11/2023, Status: Authorised

Retrieved on: 
Monday, December 18, 2023

Human medicines European public assessment report (EPAR): Ebglyss, Lebrikizumab, Date of authorisation: 16/11/2023, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Ebglyss, Lebrikizumab, Date of authorisation: 16/11/2023, Status: Authorised

Sytheon Granted 2 New US Patents on Isosorbide Diesters for Treating Atopic Dermatitis, Seeking Exclusive Partner to Bring to Market

Retrieved on: 
Wednesday, December 13, 2023

PARSIPPANY, N.J., Dec. 13, 2023 /PRNewswire/ -- Sytheon is thrilled to announce that its new turnkey product for treating Atopic Dermatitis (eczema) has further patent protection – and is actively seeking an exclusive partner to bring it to the OTC dermatological market.

Key Points: 
  • PARSIPPANY, N.J., Dec. 13, 2023 /PRNewswire/ -- Sytheon is thrilled to announce that its new turnkey product for treating Atopic Dermatitis (eczema) has further patent protection – and is actively seeking an exclusive partner to bring it to the OTC dermatological market.
  • Sytheon is thrilled to announce that its new turnkey product for treating eczema has further patent protection.
  • There is currently an unmet need for a sustainable, safe, and cost-effective product for those with mild to moderate Atopic Dermatitis (AD).
  • Sytheon is actively looking for an exclusive partnership with the right organization to bring this turnkey product to the OTC dermatological market.